ArticleChina CDC weekly2026
The Rise of Synthetic Drugs: New Challenges for Global Drug Control.
Article in China CDC weekly, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The rapid expansion of synthetic drugs poses new challenges to drug control and public health systems, reshaping patterns of drug use and drug-related harms worldwide. Low-cost production, rapid chemical modification, and sophisticated distribution networks have fueled this growth, giving rise to an increasingly complex drug market. Its regional manifestations vary - from the opioid-involved overdose crisis in the United States and the increasingly diverse synthetic drug markets in Europe to the growing misuse of narcotic and psychotropic medications in China. Yet traditional drug control systems still face critical gaps in surveillance, regulation, and treatment. Closing them will require stronger surveillance systems, new overdose-prevention technologies, closer collaboration with healthcare institutions, and expanded international cooperation through early warning systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.